相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit et al.
CIRCULATION (2020)
The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors
Ann Wan-Chin Ling et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Evidence-based and tailored medication in type 2 diabetes: a pathway learned from clinical trials
Atsushi Tanaka et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1
Tiechao Jiang et al.
MOLECULAR IMMUNOLOGY (2019)
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
Binayak Sinha et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
Yue Fei et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride
Owen L. Woodman et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2019)
Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice
Kunduziayi Aini et al.
INTERNATIONAL HEART JOURNAL (2019)
The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB
Suxia Ma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Differential effect of concomitant antidiabetic agents on carotid atherosclerosis: a subgroup analysis of the PROLOGUE study
Atsushi Tanaka et al.
HEART AND VESSELS (2019)
Alogliptin improves endothelial function by promoting autophagy in perivascular adipose tissue of obese mice through a GLP-1-dependent mechanism
Biao Zhu et al.
VASCULAR PHARMACOLOGY (2019)
Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy
Huanyuan Wang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2018)
Sitagliptin on carotid intima-media thickness in type 2 diabetes patients receiving primary or secondary prevention of cardiovascular disease: A subgroup analysis of the PROLOGUE study
Atsushi Tanaka et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration
Matthias W. Lorenz et al.
PLOS ONE (2018)
Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
Kyoung Hwa Ha et al.
KOREAN CIRCULATION JOURNAL (2018)
Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study
Yi-Sheng Liou et al.
PLOS ONE (2018)
Physiological Diagnostic Criteria for Vascular Failure
Atsushi Tanaka et al.
HYPERTENSION (2018)
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum
William T. Cefalu et al.
DIABETES CARE (2018)
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Tomoya Mita et al.
DIABETES CARE (2016)
Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study
Hirofumi Tomiyama et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study
Tatsuya Maruhashi et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial
Tomoya Mita et al.
DIABETES CARE (2016)
Vascular effects of linagliptin in non-obese diabetic mice are glucose-independent and involve positive modulation of the endothelial nitric oxide synthase (eNOS)/caveolin-1 (CAV-1) pathway
Valentina Vellecco et al.
DIABETES OBESITY & METABOLISM (2016)
Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase
Anna Solini et al.
VASCULAR PHARMACOLOGY (2016)
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial
Jun-ichi Oyama et al.
PLOS MEDICINE (2016)
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose
Salheen M. Salheen et al.
PLOS ONE (2015)
Insulin Resistance, Diabetes, and Cardiovascular Risk
Francesco Paneni et al.
CURRENT ATHEROSCLEROSIS REPORTS (2014)
The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome
Hironori Nakagami et al.
HYPERTENSION RESEARCH (2014)
Vildagliptin Stimulates Endothelial Cell Network Formation and Ischemia-induced Revascularization via an Endothelial Nitric-oxide Synthase-dependent Mechanism
Masakazu Ishii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Francesco Paneni et al.
EUROPEAN HEART JOURNAL (2013)
Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon-Like Peptide 1-Dependent Mechanism
Limei Liu et al.
HYPERTENSION (2012)
A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice
Junichi Matsubara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Nga N. Ta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
The effect of intensive glycaemic control on cardiovascular outcomes
D. Hill et al.
DIABETES OBESITY & METABOLISM (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Kausik K. Ray et al.
LANCET (2009)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of a multifactorial intervention on mortality in type 2 diabetes
Peter Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
Theodore Mazzone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies
Michiel L. Bots
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes
N Katakami et al.
DIABETOLOGIA (2004)
分享论文
